Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Our study demonstrates the importance of CTNNB1 mutations and NFE2L2-KEAP1 pathway activation in HB development and defines loss of genomic stability and TERT promoter mutations as prominent characteristics of aggressive HB with HCC features.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Our study demonstrates the importance of CTNNB1 mutations and NFE2L2-KEAP1 pathway activation in HB development and defines loss of genomic stability and TERT promoter mutations as prominent characteristics of aggressive HB with HCC features.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our study demonstrates the importance of CTNNB1 mutations and NFE2L2-KEAP1 pathway activation in HB development and defines loss of genomic stability and TERT promoter mutations as prominent characteristics of aggressive HB with HCC features.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our study demonstrates the importance of CTNNB1 mutations and NFE2L2-KEAP1 pathway activation in HB development and defines loss of genomic stability and TERT promoter mutations as prominent characteristics of aggressive HB with HCC features.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our study demonstrates the importance of CTNNB1 mutations and NFE2L2-KEAP1 pathway activation in HB development and defines loss of genomic stability and TERT promoter mutations as prominent characteristics of aggressive HB with HCC features.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our study demonstrates the importance of CTNNB1 mutations and NFE2L2-KEAP1 pathway activation in HB development and defines loss of genomic stability and TERT promoter mutations as prominent characteristics of aggressive HB with HCC features.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our study demonstrates the importance of CTNNB1 mutations and NFE2L2-KEAP1 pathway activation in HB development and defines loss of genomic stability and TERT promoter mutations as prominent characteristics of aggressive HB with HCC features.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our study demonstrates the importance of CTNNB1 mutations and NFE2L2-KEAP1 pathway activation in HB development and defines loss of genomic stability and TERT promoter mutations as prominent characteristics of aggressive HB with HCC features.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our study demonstrates the importance of CTNNB1 mutations and NFE2L2-KEAP1 pathway activation in HB development and defines loss of genomic stability and TERT promoter mutations as prominent characteristics of aggressive HB with HCC features.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1211822.RAScE6d5rMaPX7Rv6LZTI-aCJZhx3bdUd6jATcWtJRTHM130_assertion description "[Our study demonstrates the importance of CTNNB1 mutations and NFE2L2-KEAP1 pathway activation in HB development and defines loss of genomic stability and TERT promoter mutations as prominent characteristics of aggressive HB with HCC features.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211822.RAScE6d5rMaPX7Rv6LZTI-aCJZhx3bdUd6jATcWtJRTHM130_provenance.
• NP1211823.RATnhpTvnYbsZbuNUWvwrBFFwlYPuVEiJ18dWiPzQh2Vw130_assertion description "[Our study demonstrates the importance of CTNNB1 mutations and NFE2L2-KEAP1 pathway activation in HB development and defines loss of genomic stability and TERT promoter mutations as prominent characteristics of aggressive HB with HCC features.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211823.RATnhpTvnYbsZbuNUWvwrBFFwlYPuVEiJ18dWiPzQh2Vw130_provenance.
• NP1211824.RAqJ0zXBfzaabBcyqmPrgrBVRjqKy_NTmATmprct0a9MI130_assertion description "[Our study demonstrates the importance of CTNNB1 mutations and NFE2L2-KEAP1 pathway activation in HB development and defines loss of genomic stability and TERT promoter mutations as prominent characteristics of aggressive HB with HCC features.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211824.RAqJ0zXBfzaabBcyqmPrgrBVRjqKy_NTmATmprct0a9MI130_provenance.
• NP1211825.RAJ8fnoxce-2_z-OvFrnXgw5te_R0vjT1582SlEafTP5w130_assertion description "[Our study demonstrates the importance of CTNNB1 mutations and NFE2L2-KEAP1 pathway activation in HB development and defines loss of genomic stability and TERT promoter mutations as prominent characteristics of aggressive HB with HCC features.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211825.RAJ8fnoxce-2_z-OvFrnXgw5te_R0vjT1582SlEafTP5w130_provenance.
• NP1211821.RA0NzJzVj3Cs3Eg-aCT0Jf6fyQOeWLxCYNGG8vCJlt3h0130_assertion description "[Our study demonstrates the importance of CTNNB1 mutations and NFE2L2-KEAP1 pathway activation in HB development and defines loss of genomic stability and TERT promoter mutations as prominent characteristics of aggressive HB with HCC features.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211821.RA0NzJzVj3Cs3Eg-aCT0Jf6fyQOeWLxCYNGG8vCJlt3h0130_provenance.